And what is at the other end, obviously, is that you have poor control of glucose by the time you have your surgery.
As the number of new drugs increases, physicians must choose the right obesity treatment for each patient, individualising the balance of benefits and adverse effects, say the authors of a linked Editorial To view or add a comment, sign in The needle era of obesity medicine may be ending
In order to meet this moment marked by the rise of GLP-1s, we know what that looks like
Sharpe A, Morley L, Tang T, Norman R, Balen A
Genomics 48 , 755762 (2021)
FDA-approved treatments, like Wegovy and Ozempic, undergo rigorous clinical trials to ensure consistent quality, safety, and proven effectiveness for weight loss